Live feed
Filing
SC 13D
SC 13D0001839882-21-002166·Atlas Venture Fund X, L.P.
Schedule 13D ownership disclosure
Gemini Therapeutics, Inc. /DE
Security class unavailable · CUSIP: 36870G105
Event date: 2021-02-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 40,150,451
- Percent of class
- 8.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001839882-21-002166
- Form type
- SC 13D
- Filer
- Atlas Venture Fund X, L.P.
- CIK
- CIK 1628098
- Filed
- Feb 16, 2021
- Reporting period
- Feb 05, 2021
- Description
- Schedule 13D beneficial ownership